Research
Hormonal
A low glycaemic index (GI) diet increases satiety and reduces voluntary energy intake, facilitating weight loss and fat mass reduction in overweight and obese individuals.
To lose weight more easily, choose low-glycaemic index carbohydrates like pulses, legumes, and whole grains. These foods prevent the blood sugar crash that triggers intense hunger and overeating. You will naturally consume fewer calories without feeling deprived, leading to better long-term weight control.
GoodSupportsHIGH confidence
In obese or overweight individuals, low-glycaemic index meals increase satiety and facilitate the control of food intake... Obese teenage boys participated in three test meals of low, medium or high GI... They ate 53 % more energy in the 5 h after the high-GI meal compared to the medium-GI meal, and 81 % more energy after the high-GI meal compared to the low-GI meal.
Why this rating
Supported by acute feeding studies, crossover trials, and prospective cohort data.
Source
Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals
Salwa W. Rizkalla et al. · British Journal Of Nutrition · 2002
DOI 10.1079/bjn2002715
narrative_reviewCited 274×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Adopting a low glycaemic index (GI) diet improves glycaemic control (lower HbA1c and fasting glucose) and reduces insulin requirements in patients with type 1 and type 2 diabetes compared to standard or high-GI diets.Good
- A low glycaemic index (GI) diet improves lipid profiles (lower total cholesterol, triglycerides, and VLDL; higher HDL) and reduces cardiovascular disease risk in both diabetic and healthy individuals.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →